# iPSCs - Pharmacology Group Discussion
## Neurology
### Reviews
* [パーキンソン病に対する多能性幹細胞を用いた細胞移植治療の現状](https://doi.org/10.5692/clinicalneurol.cn-001235)
* pdf
* https://www.jstage.jst.go.jp/article/clinicalneurol/59/3/59_cn-001235/_article/-char/ja/
* doi
* https://doi.org/10.5692/clinicalneurol.cn-001235
### Trials
* [Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial](https://www.sciencedirect.com/science/article/pii/S1474442219301395?via%3Dihub)
## Cardiology
### Reviews
* [Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722184/)
### Trials
* [Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.](https://www.sciencedirect.com/science/article/pii/S1347861318301312?via%3Dihub)
* [International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226030/)
* [Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891061/)
* [Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy](https://stm.sciencemag.org/content/12/530/eaay8329)